Treatment Updates in MDS

 

Treatment Updates in MDS
05:27

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy and Safety Results From the Ph3 COMMANDS Trial - Evaluating Luspatercept vs. Epoetin Alfa in ESA‑Naïve Transfusion-Dependent Pts With LR-MDS"

FEATURING Matteo Della Porta
  • 256 views
  • June 14, 2023
19:18

John Bennett

Diagnosing and Prognosis for MDS in 2023: A Morphologist's Perspective

  • 199 views
  • April 25, 2023
  • 1
17:00

UChicago Medicine

Pathologist's Perspective on Diagnosing MDS-RS

FEATURING Jason Cheng
  • 100 views
  • April 20, 2023
  • 1
27:52

Indy Hematology Review

The Oracle of Apollo in Indianapolis: Prognosis and Treatment in MDS

FEATURING Richard Stone
  • 289 views
  • April 18, 2023
32:10

Total Health

MDS in 2023: Updates in Diagnosis and Treatment

FEATURING Aditi Shastri
  • 372 views
  • April 3, 2023
21:38

MDS Foundation

Anemia and Transfusion Dependence in MDS: Effects and Optimization Strategies

FEATURING Rena Buckstein
  • 182 views
  • January 4, 2023
  • 1
19:57

Yale Cancer Center

Yale Cancer Center Selected Updates in MDS

FEATURING Amer Zeidan
  • 414 views
  • March 15, 2023
  • 1
07:17

Sangeetha Venugopal

Management and Treatment of Lower-Risk MDS

  • 168 views
  • December 16, 2022
  • 3
23:33

Francesca Vinchi

Addressing Iron Overload in Transfusion Dependent LR-MDS: Mechanisms, Consequences, and Management

  • 62 views
  • January 5, 2023
  • 2
14:09

Moshe Mittelman

Current Treatment Options in Management of Anemia in LR-MDS: 1L and 2L Approaches

  • 182 views
  • January 13, 2023
  • 2
06:55

ASH 2022 Conference Coverage

Luspatercept for Treatment of LR-MDS: Real World Data Replicates MEDALIST Study Results and Confirms Activity Among HMAs and Lenalidomide Treated Pts

FEATURING Rami Komrokji
  • 320 views
  • December 22, 2022
  • 1
06:06

ASH 2022 Conference Coverage

Synergistic Activity of Luspatercept and Erythroid Stimulating Agents Combination for Treatment of Anemia in LR-MDS

FEATURING Rami Komrokji
  • 270 views
  • December 22, 2022
  • 3
19:03

Talha Badar

Low Risk-MDS: Background, Treatment Options, and Case Presentation

  • 355 views
  • December 6, 2022
  • 3
11:15

SOHO 2022 Tenth Annual Meeting

Next Questions: Myelodysplastic Syndromes

FEATURING Guillermo Garcia-Manero
  • 184 views
  • October 14, 2022
  • 1
08:11

ASH 2022 Conference Coverage

Validation of 2022 WHO & ICC Classifications in MDS - An Analysis on Behalf of the icMDS

FEATURING Somedeb Ball
  • 169 views
  • December 19, 2022
  • 4
31:13

ASH 2022 Conference Coverage

Selected Updates in MDS

FEATURING Amer Zeidan
  • 469 views
  • February 14, 2023
  • 2
05:09

ASH 2022 Conference Coverage

MEDALIST Study: Multiple Episodes of Transfusion Independence With Luspatercept Treatment and the Impact of Dose Escalation in Pts With LR-MDS

FEATURING Uwe Platzbecker
  • 178 views
  • February 16, 2023
16:39

Current Challenges in Hematology

LR-MDS 2023: Standards and Perspectives

FEATURING Uwe Platzbecker
  • 213 views
  • February 21, 2023
  • 1
16:56

Current Challenges in Hematology

Targeting Inflammation in LR-MDS

FEATURING Anne Sophie Kubasch
  • 68 views
  • February 21, 2023